コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 n (hRTN(+/-)(/-)) but are deficient in mouse resistin.
2 tissues from adult rat hearts overexpressing resistin.
3 ng 12.1% and 8.5% of variance in circulating resistin.
4 /EBPbeta) expression vectors with or without resistin.
5 an articular chondrocytes were cultured with resistin.
6 al and high-molecular-weight adiponectin and resistin.
7 The RETN gene encodes the adipokine resistin.
8 eptor, also prevented the effects of central resistin.
9 due to reduced expression and circulation of resistin.
10 ate pituitaries expressed leptin/adiponectin/resistin.
11 may be transduced, in part, by its impact on resistin.
12 ormal T cell expressed and secreted PDGF and RESISTIN.
13 fold, angiotensinogen 3-fold, leptin 2-fold, resistin 4-fold, and adiponectin 4-fold; P<0.01 compared
14 experiments showed that pre-incubation with resistin (40 ng/ml) significantly impaired the ability o
16 onectin concentrations, as well as 16% lower resistin, 41% lower CRP, 19% lower sE-selectin, and 24%
17 ximally adjusted model, each SD increment in resistin (7.45 ng/ml) was associated with a 26% increase
21 d inflammation and suggest that hypothalamic resistin action can contribute to hyperglycemia in type
22 that bi-directional changes in hypothalamic resistin action have dramatic effects on GP and proinfla
26 We compared serum concentrations of leptin, resistin, adiponectin, and visfatin in 167 RA patients a
27 al and circulating levels of adipocytokines (resistin, adiponectin, leptin, tumor necrosis factor [TN
28 ly improved by the simultaneous inclusion of resistin, adipsin, and total adiponectin (c-statistic: 0
31 roperties of 4 plasma adipocytokines, namely resistin, adipsin, leptin, and total adiponectin, with r
32 amined whether the human-specific variant of resistin affects neutrophil activation and the severity
35 tion was assessed by measurement of secreted resistin, an azurophilic granule marker, and by determin
38 We tested the association of the adipokines resistin and adiponectin with incident heart failure.
39 mainly influenced the circulating levels of resistin and adiponectin, whereas both obesity and perio
40 The data further show that repression of resistin and angiotensinogen expression involves recruit
42 of cytokine signaling-3 (Socs3), a target of resistin and hepcidin implicated in insulin resistance.
44 he role of three key adipokines-adiponectin, resistin and leptin-as potential predictors of response
45 ment of secreted azurophilic granule protein resistin and profiling of the secretome, using mass spec
47 l growth factor, myeloperoxidase, prolactin, resistin and soluble tumor necrosis factor alpha recepto
50 PC-expressing adipokines (e.g., adiponectin, resistin, and glucagon-like peptide 1 [GLP-1]) were coun
51 romoters of white fat-specific genes such as resistin, and is abolished in the genetic absence of CtB
53 fat transplants contained increased leptin, resistin, and monocyte chemoattractant protein-1 compare
58 4-h serum interleukin-6, C-reactive protein, resistin, and tumor necrosis factor-alpha levels by 3-29
59 nd serum adipocytokine (leptin, adiponectin, resistin, and visfatin) concentrations were determined i
61 fat genes ("visceral white"), including the resistin, angiotensinogen, and chemerin genes, in additi
64 ignificantly less inflammatory cytokines and resistin as compared with MIF(+/+) mice and failed to de
65 n concentrations and lower concentrations of resistin, as well as biomarkers of inflammation, endothe
66 (24 h) with the following: 1) purified human resistin at various concentrations, with and without lov
68 erial artificial chromosome containing human resistin (BAC-Retn), whose expression was similar to tha
70 ory states, we generated mice lacking murine resistin but transgenic for a bacterial artificial chrom
72 A significant difference was observed in GCF resistin concentrations from group 1 versus group 2 (P =
77 ltration rate) using the lowest third of the resistin distribution as the referent, the hazard ratios
78 e other ancestry populations, we showed that resistin does not seem to increase insulin resistance an
80 sitize neutrophils to LPS stimulation, human resistin enhanced neutrophil extracellular trap formatio
82 ubsequent western blot validation identified resistin expression to be increased approximately 2-fold
85 elationship between the CRD of PCSK9 and the resistin family is not observed in primary sequence comp
86 HF diet-induced elevations of plasma leptin, resistin, fed-state and fasting insulin and increased ex
88 d the expression of known adipogenic factors resistin, galectin-12, sterol response-element-binding p
90 two SNPs were significantly associated with resistin gene (RETN) mRNA levels in white blood cells fr
92 In addition it causes IR, higher hepatic resistin gene expression, and up-regulation of hepatic i
93 ent study was initiated to determine whether resistin has additional roles in GIP-regulated adipocyte
98 roup box (HMGB)-1, B7 Homolog 1, S100A4, and resistin have been detected in tissues of dermatomyositi
100 , plasminogen activator inhibitor-1 (PAI-1), resistin, hepatocyte growth factor, interleukin-6 (IL-6)
101 ed for the qualitative analysis of the human resistin homodimer from normal (healthy) plasma samples.
102 wing a distinct structural similarity to the resistin homotrimer, a small cytokine associated with ob
106 resistin mice that exclusively express human resistin (hRTN(+/-)(/-)) but are deficient in mouse resi
107 i) serum hormone concentrations (leptin and resistin), ii) adipose tissue mRNA expression of inflamm
112 d by antibody-immunoprecipitation removal of resistin in human serum, which decreased serum stimulati
115 The quantitatively important role of human resistin in LDLR expression was demonstrated by antibody
116 These findings indicate a novel role for resistin in mediating sex-dependent vascular function in
117 a central role in the genetic regulation of resistin in monocytes along with promoter methylation.
118 or galectin-12 and SREBP-1 in the nuclei and resistin in the cytoplasm of basal sebocytes, and stearo
119 e results strongly support the role of human resistin in the development of insulin resistance in inf
120 udy is to estimate and compare the levels of resistin in the gingival crevicular fluid (GCF) in healt
121 learly identify TLR4 as the binding site for resistin in the hypothalamus and bring new insight into
122 p-regulation of the LDLR by 60%, implicating resistin in the relative ineffectiveness of statins in s
123 an altered adipokine response (i.e., higher resistin increase and an adiponectin fall), and hepatocy
124 and did not alter LH/FSH/TSH-release; and 3) resistin increased ACTH-release and did not alter PRL/LH
125 ally, we report that intracerebroventricular resistin increased plasma FGF21 levels and downregulated
127 normal-weight bone explant with recombinant resistin increased the Type I collagen alpha1/alpha2 rat
128 n of primary OA osteoblasts with recombinant resistin increased Wnt signalling activation, osteoblast
129 zation analyses did not provide evidence for resistin increasing insulin resistance, body mass index,
131 to elucidate the mechanisms associated with resistin-induced cardiac hypertrophy and myocardial insu
133 trally mediated mechanisms partially control resistin-induced expression of TNF-alpha, IL-6, and SOCS
134 ranscriptional up-regulation are involved in resistin-induced gene expression in human chondrocytes.
135 ht into the molecular mechanisms involved in resistin-induced inflammation and insulin resistance in
138 We show that chronic intracerebroventricular resistin infusion downregulated both hypothalamic and he
139 In the current study, we report that chronic resistin infusion in the lateral cerebral ventricle of n
145 receptors (TLR)2, TLR4, and TLR9, as well as resistin, interleukins (IL)-1beta, IL-4, and IL-6 and ox
146 These findings provide clear evidence that resistin is a clinically relevant endogenous ligand for
147 These results reveal for the first time that resistin is a highly attractive therapeutic target in am
150 rease in resistin was also observed; because resistin is a potent pro-inflammatory compound, this dec
156 at the human homolog of RELMalpha, human (h) resistin, is upregulated in macrophage-like inflammatory
158 onectin, an insulin-sensitizing hormone, and resistin, known to promote insulin resistance, constitut
159 luding tumor necrosis factor, interleukin-6, resistin, leptin, and monocyte chemotactic protein-1, an
160 ' side of RETN were strongly associated with resistin levels (all minor alleles associated with highe
161 of hypertension, but the association between resistin levels and incident hypertension is unknown.
162 us acute kidney injury still showed elevated resistin levels and inhibited neutrophilic-differentiate
163 We examined the association between plasma resistin levels and the risk for incident hypertension a
165 riant as likely causal affecting circulating resistin levels as a cis-eQTL increasing RETN expression
166 ) and the NDST4 gene (4q25), associated with resistin levels at a genome-wide significant level, best
167 s to infer genetic causality for circulating resistin levels by performing genome-wide association st
169 In this study, we observed that high serum resistin levels in breast cancer patients positively cor
170 -wide association (GWA) study on circulating resistin levels in individuals of European ancestry draw
171 After adjustment for potential confounders, resistin levels in the highest tertile conferred a 75% h
175 atin; and 2) obese human serum with elevated resistin levels or serum from which resistin was removed
176 all the samples were analyzed together, GCF resistin levels positively correlated with GI, PD, PI, R
177 association of SNP -420C/G (rs1862513) with resistin levels remained significant (P = 0.0009) but wi
178 for these biomarkers and C-reactive protein, resistin levels remained significantly associated with i
179 lammatory and endothelial biomarkers, plasma resistin levels significantly correlated with IL-6, solu
180 GCF (4 muL) was collected and analyzed for resistin levels using an enzyme-linked immunosorbent ass
181 ariate model without body mass index, higher resistin levels were associated with a higher risk for d
183 irculating insulin, adiponectin, leptin, and resistin levels were measured in 36 patients with advanc
185 We found that BAC-Retn mice have circulating resistin levels within the normal human range, and simil
186 in the 3' region of RETN are associated with resistin levels, and one of them is also associated with
187 Framingham Offspring Study participants for resistin levels, glycemic phenotypes, and incident diabe
188 in RETN and tested associations with plasma resistin levels, risk of diabetes, and glycemic traits.
193 (which have elevated levels of the cytokine resistin-like beta, RELMbeta, and are extremely sensitiv
194 sensitivity and a marked reduction in serum Resistin-like molecule (RELM) alpha, a multifunctional c
195 of Arginase 1, chitinase-like molecules, and resistin-like molecule (RELM) alpha/FIZZ1; however, the
197 in inflammatory zone (FIZZ) 2, also known as resistin-like molecule (RELM)-beta, belongs to a novel c
201 ulomatous inflammation, increased numbers of resistin-like molecule alpha(+) cells, and enhanced coll
202 so known as found in inflammatory zone 1 and resistin-like molecule alpha, belongs to a novel class o
203 that expressed a smooth muscle cell mitogen, resistin-like molecule alpha, but surprisingly, there wa
204 protein product of the most promising gene, resistin-like molecule alpha, demonstrated a significant
206 3 production in IL-33-deficient mice impairs resistin-like molecule beta (RELMbeta) expression and eo
207 The secreted goblet cell-derived protein resistin-like molecule beta (RELMbeta) has been implicat
212 increase in secretion of goblet cell-derived resistin-like molecule beta into the intestinal lumen.
218 istin, and its closely related homologs, the resistin-like molecules (RELMs) have been implicated in
219 ore, HIF2alpha induced the expression of the resistin-like molecules alpha and beta (RELMalpha and be
221 in, insulin resistance, leptin, adiponectin, resistin, liver function enzymes, fetuin-A, body composi
227 e tissue, including leptin, adiponectin, and resistin, may influence osteoarthritis though direct joi
228 e of the molecular regulators of leptin- and resistin-mediated transcriptional induction of PCSK9.
229 In LPS-induced acute lung injury, humanized resistin mice demonstrated enhanced production of proinf
230 , experiments were performed using humanized resistin mice that exclusively express human resistin (h
233 t we believe to be a novel site of action of resistin on GP and inflammation and suggest that hypotha
236 istrated with recombinant mouse resistin (rm-resistin), or exposed to media from Lmo4-overexpressed 3
237 3), lower serum IL-(P = 0.0022), lower serum resistin (P = 0.0043), lower serum OVA-specific IgE (P =
238 atin (P = 0.06), adiponectin (P = 0.55), and resistin (P = 0.98) showed no association with the HOMA-
239 is study, our goal was to determine if human resistin plays a role in regulating the uptake of athero
240 lin resistance to obesity, the role of human resistin, predominantly expressed in mononuclear cells a
244 We also found evidence for a QTL influencing resistin protein levels (LOD score 5.3) on chromosome 14
250 ogenic factor (HIMF) is a member of the FIZZ/resistin/RELM family of proteins that we have shown to h
252 centrations of TNF-alpha, IL-6, adiponectin, resistin, retinol binding protein-4, or intraabdominal f
253 ha, IL-6, high-molecular-weight adiponectin, resistin, retinol binding protein-4, or intraabdominal o
254 was positively associated with expression of resistin (RETN) and negatively associated with expressio
255 Unlike expression of Retn in mouse, human resistin (RETN) is expressed primarily in macrophages.
256 chromosome 19p13 affecting the abundance of resistin (RETN) mRNA in the omental adipose tissue of ba
257 Rhox5-regulated genes are insulin 2 (Ins2), resistin (Retn), and adiponectin (Adipoq), all of which
259 tocytes administrated with recombinant mouse resistin (rm-resistin), or exposed to media from Lmo4-ov
261 ur results suggest a regulatory role of Lmo4-resistin signaling in weight cycling, indicating a cross
262 he interplay between adiponectin, FGF21, and resistin signaling pathways during the onset of insulin
263 eukin-8, monocyte chemoattractant protein-1, resistin, soluble interleukin-1 receptor I, soluble inte
264 alysis showed the expression of galectin-12, resistin, SREBP-1, and stearoyl-CoA desaturase mRNAs in
267 ted that levels of the adipokines leptin and resistin, the inflammatory marker myeloperoxidase (MPO),
268 protein metabolism, is induced by leptin and resistin through the involvement of the inflammatory pat
269 n resistance onset orchestrated by a central resistin-TLR4 pathway that impairs adiponectin signaling
272 ime, to our knowledge, the direct binding of resistin to Toll-like receptor (TLR) 4 receptors in the
276 transcription inhibitor actinomycin D after resistin treatment or with the NF-kappaB inhibitor IKK-N
277 d in Retn(+/-) and Retn(-/-) adipocytes, but resistin treatment rescued LPL responsiveness to GIP.
290 rage, TGF-beta was elevated (P = 0.0052) and resistin was lower (P = 0.0052) in patients compared wit
292 elevated resistin levels or serum from which resistin was removed via antibody-immunoprecipitation.
295 Increased circulating concentrations of resistin were associated with incident heart failure, ev
297 iation studies and fine-mapping analyses for resistin were performed in 5621 African-ancestry individ
300 flammatory proteins CCL3 and CCL4 as well as resistin, which augments monocyte-endothelial adhesion.